RenovoRx Inc.
Delivering diagnostic and therapeutic fluids directly to the pancreas
This article was originally published in Start Up
Executive Summary
Pancreatic cancer is currently the fourth leading cause of cancer death in the US, and it is primarily treated with systemic drugs that have limited ability to penetrate the pancreas. RenovoRx Inc. has developed an endovascular catheter that enables targeted delivery of either diagnostic or therapeutic fluids directly to the pancreas.